Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00200785 · ClinicalTrials.gov registry record · NA

Identifying the Anti-Blood-Clotting Compounds in Garlic

A NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT00200785 is a NA study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00200785, a NA study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

This study will seek to identify the compound(s) in garlic that is (are) responsible for its ability to prevent the formation of blood clots (prevent platelet aggregation) and to determine the maximally effective dose and duration of the benefits. This study will also determine whether "cooked" garlic (garlic powder added to boiling water, no allicin present) is as effective as "fresh" garlic (garlic powder added to ambient water, high allicin present) and, if more than one compound is involved, and whether their combined effects are more significant than the effects of each compound alone.

Interventions

  • DIETARY_SUPPLEMENT garlic powder added to ambient water
  • DIETARY_SUPPLEMENT garlic powder added to boiling water

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2006-03
Est. Completion 2007-09
Phase NA

What the Registry Record Tells You About NCT00200785

The ClinicalTrials.gov registry entry for NCT00200785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which garlic powder added to ambient water is the first listed.

NCT00200785 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00200785 about?

NCT00200785 is a clinical study titled "Identifying the Anti-Blood-Clotting Compounds in Garlic". This study will seek to identify the compound(s) in garlic that is (are) responsible for its ability to prevent the formation of blood clots (prevent platelet aggregation) and to determine the maximally effective dose and duration of the benefits. This study will also determine whether "cooked" garl...

What is the current status of trial NCT00200785?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2006-03. Estimated completion is 2007-09.

What interventions are being tested in trial NCT00200785?

The interventions under investigation include: garlic powder added to ambient water (DIETARY_SUPPLEMENT), garlic powder added to boiling water (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00200785?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.